Unusual 11 Mid-Day Movers 04/19: (VRTX) (RH) (HWAY) Higher; (ACTG) (PRGX) (AIRM) Lower
Tweet
Share
E-mail
Get Alerts VRTX Hot Sheet
Join SI Premium – FREE
Vertex Pharmaceuticals, Inc. (Nasdaq: VRTX) 59.5% HIGHER; announced data from a Phase 2 study of VX-661 and ivacaftor that showed statistically significant improvements in lung function among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, known as F508del.
Acacia Research (Nasdaq: ACTG) 22.6% LOWER; reported Q1 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $76.86 million versus the consensus estimate of $58.68 million.
Restoration Hardware Holdings (NYSE: RH) 20.8% HIGHER; reported Q4 EPS of $0.64, $0.04 better than the analyst estimate of $0.60. Revenue for the quarter came in at $398.05 million versus the consensus estimate of $390.86 million. Sees Q1 2013 EPS of ($0.02)- $0.00, versus the consensus of ($0.04). Also sees Q1 2013 revenue of $280-$285 million, versus the consensus of $253.08 million.
Overstock.com, Inc. (Nasdaq: OSTK) 17.8% HIGHER; reported Q1 EPS of $0.32, versus $0.12 reported last year.
Healthways, Inc. (Nasdaq: HWAY) 17.1% HIGHER; reported Q1 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $165.17 million versus the consensus estimate of $162.81 million.
Novadaq Technologies Inc. (Nasdaq: NVDQ) 13.7% HIGHER; announced that interim results from PILLAR(TM)II, Perfusion Assessment in Laparoscopic Left Anterior Resection, were presented during the 2013 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting which is being held in Baltimore, MD from April 17-20. PILLAR II is a multi-center, prospective study of patients undergoing laparoscopic left anterior resection (LAR) of the colon during which PINPOINT imaging is performed. The study is intended to evaluate the clinical impact of PINPOINT real-time visual perfusion assessment on the surgical decision-making process and on surgical outcomes of laparoscopic colon resection surgery in up to 150 patients.
Anacor Pharmaceuticals, Inc. (Nasdaq: ANAC) 13.5% HIGHER; has been moving up since quarterly results last month and getting a $22.7 million research grant from the Gates foundation earlier this month. Popping above the $8 level today.
PRGX Global, Inc. (Nasdaq: PRGX) 13.5% LOWER; sees Q1 loss of $0.01 to $0.03 per share, versus expectations calling for EPS of $0.02. For more color on the outlook, click here.
Air Methods Corp (Nasdaq: AIRM) 12.8% LOWER; said preliminary net revenue per community-based transport for the first quarter 2013 was $9,108, as compared with $10,072 in the prior-year quarter, a 10% decrease. This decrease was almost entirely attributed to deterioration in the percentage of privately insured patients transported, which declined from 36% to 32% of total patients transported, compared with fourth quarter of 2012. As a result of these factors, the Company expects to report a net loss of approximately $0.14 to $0.16 per share for the first quarter of 2013, compared with net income of $0.32 per share in the prior-year quarter. The consensus is $0.32.
Insight Enterprises, Inc. (Nasdaq: NSIT) 11.4% LOWER; sees Q1 EPS of $0.22 - $0.27, with the consensus of $0.37.
Rambus, Inc. (Nasdaq: RMBS) 10.8% LOWER; reported Q1 EPS of $0.11, $0.01 better than the analyst estimate of $0.10. Revenue for the quarter came in at $66.9 million versus the consensus estimate of $67 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Acacia Research (Nasdaq: ACTG) 22.6% LOWER; reported Q1 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $76.86 million versus the consensus estimate of $58.68 million.
Restoration Hardware Holdings (NYSE: RH) 20.8% HIGHER; reported Q4 EPS of $0.64, $0.04 better than the analyst estimate of $0.60. Revenue for the quarter came in at $398.05 million versus the consensus estimate of $390.86 million. Sees Q1 2013 EPS of ($0.02)- $0.00, versus the consensus of ($0.04). Also sees Q1 2013 revenue of $280-$285 million, versus the consensus of $253.08 million.
Overstock.com, Inc. (Nasdaq: OSTK) 17.8% HIGHER; reported Q1 EPS of $0.32, versus $0.12 reported last year.
Healthways, Inc. (Nasdaq: HWAY) 17.1% HIGHER; reported Q1 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $165.17 million versus the consensus estimate of $162.81 million.
Novadaq Technologies Inc. (Nasdaq: NVDQ) 13.7% HIGHER; announced that interim results from PILLAR(TM)II, Perfusion Assessment in Laparoscopic Left Anterior Resection, were presented during the 2013 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting which is being held in Baltimore, MD from April 17-20. PILLAR II is a multi-center, prospective study of patients undergoing laparoscopic left anterior resection (LAR) of the colon during which PINPOINT imaging is performed. The study is intended to evaluate the clinical impact of PINPOINT real-time visual perfusion assessment on the surgical decision-making process and on surgical outcomes of laparoscopic colon resection surgery in up to 150 patients.
Anacor Pharmaceuticals, Inc. (Nasdaq: ANAC) 13.5% HIGHER; has been moving up since quarterly results last month and getting a $22.7 million research grant from the Gates foundation earlier this month. Popping above the $8 level today.
PRGX Global, Inc. (Nasdaq: PRGX) 13.5% LOWER; sees Q1 loss of $0.01 to $0.03 per share, versus expectations calling for EPS of $0.02. For more color on the outlook, click here.
Air Methods Corp (Nasdaq: AIRM) 12.8% LOWER; said preliminary net revenue per community-based transport for the first quarter 2013 was $9,108, as compared with $10,072 in the prior-year quarter, a 10% decrease. This decrease was almost entirely attributed to deterioration in the percentage of privately insured patients transported, which declined from 36% to 32% of total patients transported, compared with fourth quarter of 2012. As a result of these factors, the Company expects to report a net loss of approximately $0.14 to $0.16 per share for the first quarter of 2013, compared with net income of $0.32 per share in the prior-year quarter. The consensus is $0.32.
Insight Enterprises, Inc. (Nasdaq: NSIT) 11.4% LOWER; sees Q1 EPS of $0.22 - $0.27, with the consensus of $0.37.
Rambus, Inc. (Nasdaq: RMBS) 10.8% LOWER; reported Q1 EPS of $0.11, $0.01 better than the analyst estimate of $0.10. Revenue for the quarter came in at $66.9 million versus the consensus estimate of $67 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
